Aenova is a leading CDMO in the global pharmaceutical industry. With operations in Europe and the US, services span from early phase development to commercial manufacturing for all common dosage forms from solids to sterile injectables. Specialty technologies include HPAPI, micro-dosing, modified release, organic granulation, particulate systems, lipid-based systems, hot melt extrusion or spray drying for poorly soluble compounds. Excellence and Reliability are core Aenova values, reflected through ample capacities, backup sourcing within the group, and ongoing capital investments, resulting in strong and enduring client partnerships.
No hay comentarios disponibles.
Deja tu valoración & comentario